Creo Medical Group (STU:1RC) YoY EBITDA Growth : 61.04% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Creo Medical Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 61.04%.

Creo Medical Group's EBITDA per Share for the six months ended in Dec. 2023 was €-0.03.

Creo Medical Group YoY EBITDA Growth Historical Data

The historical data trend for Creo Medical Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group YoY EBITDA Growth Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-5.00

11.90

-27.70

11.11

54.17

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial												-48.10	-32.86	34.19	46.24	61.04

Creo Medical Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Creo Medical Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.077	-	-0.168)	/	\| -0.168 \|
=	54.17 %

Creo Medical Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.03	-	-0.077)	/	\| -0.077 \|
=	61.04 %

Creo Medical Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (STU:1RC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (STU:1RC) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CREO:UK

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (STU:1RC) Headlines

No Headlines